Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
Abeona Therapeutics (Nasdaq: ABEO) has announced its participation in three upcoming investor conferences in September 2024:
- Wells Fargo Healthcare Conference on September 5, featuring investor meetings
- H.C. Wainwright Annual Global Investment Conference on September 10, including a company presentation at 1:30 p.m. ET and investor meetings
- Cantor Global Healthcare Conference on September 19, featuring a fireside chat at 9:45 a.m. ET and investor meetings
Live webcasts of the presentation and fireside chat will be available on the Investors section of Abeona's website under 'Events'. Replays will also be accessible for a time after the events.
Abeona Therapeutics (Nasdaq: ABEO) ha annunciato la sua partecipazione a tre prossime conferenze per investitori nel settembre 2024:
- Conferenza Sanitaria Wells Fargo il 5 settembre, con incontri con gli investitori
- Conferenza Annuale di Investimento Globale H.C. Wainwright il 10 settembre, che include una presentazione dell'azienda alle 13:30 ET e incontri con gli investitori
- Conferenza Sanitaria Globale Cantor il 19 settembre, con una chiacchierata informale alle 9:45 ET e incontri con gli investitori
Le dirette web delle presentazioni e della chiacchierata informale saranno disponibili nella sezione Investitori del sito di Abeona sotto 'Eventi'. Le registrazioni saranno inoltre accessibili per un certo periodo dopo gli eventi.
Abeona Therapeutics (Nasdaq: ABEO) ha anunciado su participación en tres próximas conferencias para inversores en septiembre de 2024:
- Conferencia de Salud de Wells Fargo el 5 de septiembre, con reuniones para inversores
- Conferencia Anual de Inversión Global H.C. Wainwright el 10 de septiembre, incluyendo una presentación de la empresa a la 1:30 p.m. ET y reuniones para inversores
- Conferencia Global de Salud Cantor el 19 de septiembre, con una charla informal a las 9:45 a.m. ET y reuniones para inversores
Las transmisiones en vivo de la presentación y de la charla informal estarán disponibles en la sección de Inversores del sitio web de Abeona bajo 'Eventos'. También se podrá acceder a las grabaciones durante un tiempo después de los eventos.
아베오나 테라퓨틱스 (Nasdaq: ABEO)는 2024년 9월에 열릴 세 가지 투자자 컨퍼런스에 참여할 예정이라고 발표했습니다:
- 9월 5일 웰스 파고 헬스케어 컨퍼런스 (투자자 회의 포함)
- 9월 10일 H.C. 웨인라이트 연례 글로벌 투자 컨퍼런스 (오후 1시 30분 ET에 회사 발표 및 투자자 회의 포함)
- 9월 19일 칸토 글로벌 헬스케어 컨퍼런스 (오전 9시 45분 ET에 파이어사이드 챗 및 투자자 회의 포함)
발표 및 파이어사이드 챗의 생중계는 아베오나 웹사이트의 투자자 섹션 이벤트에서 확인할 수 있으며, 행사 후 일정 시간 동안 재생도 가능합니다.
Abeona Therapeutics (Nasdaq: ABEO) a annoncé sa participation à trois prochaines conférences pour investisseurs en septembre 2024 :
- Conférence de Santé Wells Fargo le 5 septembre, avec des réunions d'investisseurs
- Conférence Annuelle d'Investissement Global H.C. Wainwright le 10 septembre, incluant une présentation de l'entreprise à 13h30 ET et des réunions d'investisseurs
- Conférence de Santé Globale Cantor le 19 septembre, avec une discussion informelle à 9h45 ET et des réunions d'investisseurs
Des webcasts en direct de la présentation et de la discussion informelle seront disponibles dans la section Investisseurs du site d'Abeona sous 'Événements'. Des rediffusions seront également accessibles pendant un certain temps après les événements.
Abeona Therapeutics (Nasdaq: ABEO) hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben:
- Wells Fargo Healthcare Conference am 5. September, mit Investorenmeetings
- H.C. Wainwright Annual Global Investment Conference am 10. September, einschließlich einer Unternehmenspräsentation um 13:30 Uhr ET und Investorenmeetings
- Cantor Global Healthcare Conference am 19. September, mit einem Fireside-Chat um 9:45 Uhr ET und Investorenmeetings
Live-Webcasts der Präsentation und des Fireside Chats sind in der Investoren-Sektion der Abeona-Website unter 'Events' verfügbar. Aufzeichnungen werden auch für eine gewisse Zeit nach den Veranstaltungen zugänglich sein.
- None.
- None.
CLEVELAND, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2024:
- Wells Fargo Healthcare Conference: Investor meetings on Thursday, September 5, 2024.
- H.C. Wainwright Annual Global Investment Conference: Company presentation on Tuesday, September 10, 2024 at 1:30 p.m. ET and investor meetings.
- Cantor Global Healthcare Conference: Fireside chat on Thursday, September 19, 2024 at 9:45 a.m. ET and investor meetings.
A live webcast of the presentation and fireside chat can be accessed on the Investors section of the Abeona website under "Events" at https://investors.abeonatherapeutics.com/events, where a replay of the events will also be available for a limited time.
About Abeona Therapeutics
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa. The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. For more information, visit www.abeonatherapeutics.com.
Forward-Looking Statements
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties. We have attempted to identify forward-looking statements by such terminology as “may,” “will,” “believe,” “anticipate,” “expect,” “intend,” “potential,” and similar words and expressions (as well as other words or expressions referencing future events, conditions or circumstances), which constitute and are intended to identify forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, numerous risks and uncertainties, including but not limited to, the timing and results of ongoing testing and other corrective actions being performed in response to the FDA’s identified deficiencies, which could delay the Company’s BLA resubmission; the timing and outcome of the FDA’s review of our resubmission; the FDA’s grant of a Priority Review Voucher upon approval; continued interest in our rare disease portfolio; our ability to enroll patients in clinical trials; the outcome of future meetings with the FDA or other regulatory agencies, including those relating to preclinical programs; the ability to achieve or obtain necessary regulatory approvals; the impact of any changes in the financial markets and global economic conditions; risks associated with data analysis and reporting; and other risks disclosed in the Company’s most recent Annual Report on Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to revise the forward-looking statements or to update them to reflect events or circumstances occurring after the date of this press release, whether as a result of new information, future developments or otherwise, except as required by the federal securities laws.
FAQ
What investor conferences is Abeona Therapeutics (ABEO) attending in September 2024?
When is Abeona Therapeutics (ABEO) presenting at the H.C. Wainwright Annual Global Investment Conference?
Where can I watch the live webcast of Abeona Therapeutics' (ABEO) presentations at the investor conferences?
What type of event is Abeona Therapeutics (ABEO) participating in at the Cantor Global Healthcare Conference?
